Client Alert: What the Sunshine Act Final Regulations Mean to Physicians and Drug and Device Manufacturers


The Centers for Medicare & Medicaid Services (“CMS”) recently released the long-awaited rule relating to Transparency Reports and Reporting of Physician Ownership or Investment Interests – more commonly known as the Sunshine Act. This Health Law Practice Group Update provides a detailed overview of the regulations which require that applicable manufacturers of drugs, medical devices, biologicals and medical supplies as well as applicable group purchasing organizations (“GPOs”) disclose payments or other transfers of value to covered recipients.